Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Main biologic and clinic features at presentation and treatment results in very elderly patients ( 75 Years) with  Multiple myeloma: A multicentric experience

View Full Paper
Ask AI
Bookmark
Share

Authors

CLCarmine LiberatoreGAGiusy AntolinoSGSilvia Gentili

Discussion

Loading...

Member takes

Overview

Multicentric study reports treatment results in patients over 75 with multiple myeloma, suggesting promising outcomes.

Key Points

  • To analyze clinic and biologic features and treatment results in patients over 75 years diagnosed with multiple myeloma.
  • Real-life multicentric study across 10 Italian centers
  • Analysis of biologic features and treatment choices
  • Evaluation of treatment outcomes based on SLIM-CRAB criteria
  • 81% overall response rate to first-line treatment
  • 58.5% survival rate at last follow-up
  • Elevated β2-microglobulin associated with poor prognosis

Cite This Study

Liberatore et al. (2025) studied this question.

synapsesocial.com/papers/69362f714fa91c937236e175https://doi.org/10.1182/blood-2025-5777
View Full Paper
Ask AI
Bookmark
Share